This Article Full Text Full Text (PDF) CME: Take the course for this article: Stroke: June 2008, Volume 39, Number 6 All Versions of this Article: 39/6/1901    most recent STROKEAHA.107.501825v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation Pubmed/NCBI databases Medline Plus Health Information Atrial Fibrillation Stroke Related Collections Coumarins Embolic stroke Primary and Secondary Stroke Prevention Anticoagulants

(Stroke. 2008;39:1901.)
© 2008 American Heart Association, Inc.

Progress Reviews

Comparison of 12 Risk Stratification Schemes to Predict Stroke in Patients With Nonvalvular Atrial Fibrillation

*See Appendix for Working Group participants and affiliations.

Correspondence to Robert G. Hart, MD, Department of Neurology, University of Texas Health Science Center, 7703 Floyd Curl Drive MC 7883, San Antonio, TX 78229-3900; E-mail Hartr{at}uthscsa.edu

Background and Purpose— More than a dozen schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation have been published. Differences among these schemes lead to inconsistent stroke risk estimates for many atrial fibrillation patients, resulting in confusion among clinicians and nonuniform use of anticoagulation.

Methods— Twelve published schemes stratifying stroke risk in patients with nonvalvular atrial fibrillation are analyzed, and observed stroke rates in independent test cohorts are compared with predicted risk status.

Results— Seven schemes were based directly on event-rate analyses, whereas 5 resulted from expert consensus. Four considered only clinical features, whereas 7 schemes included echocardiographic variables. The number of variables per scheme ranged from 4 to 8 (median, 6). The most frequently included features were previous stroke/TIA (100% of schemes), patient age (83%), hypertension (83%), and diabetes (83%), and 8 additional variables were included in 1 schemes. Based on published test cohorts, all 8 tested schemes stratified stroke risk, but the absolute stroke rates varied widely. Observed rates for those categorized as low risk ranged from 0% to 2.3% per year and those categorized as high risk ranged from 2.5% to 7.9% per year. When applied to the same cohorts, the fractions of patients categorized by the different schemes as low risk varied from 9% to 49% and those categorized by the different schemes as high-risk varied from 11% to 77%.

Conclusions— There are substantial, clinically relevant differences among published schemes designed to stratify stroke risk in patients with atrial fibrillation. Additional research to identify an optimum scheme for primary prevention and subsequent standardization of recommendations may lead to more uniform selection of patients for anticoagulant prophylaxsis.

Key Words: atrial fibrillation • clinical prediction rules • risk factors • stroke

This article has been cited by other articles:

				M. M. Sood, P. Komenda, A. R. Sood, C. Rigatto, and J. Bueti The Intersection of Risk and Benefit: Is Warfarin Anticoagulation Suitable for Atrial Fibrillation in Patients on Hemodialysis? Chest, October 1, 2009; 136(4): 1128 - 1133. [Abstract] [Full Text] [PDF]

				R. G. Hart and J. L. Halperin Do Current Guidelines Result in Overuse of Warfarin Anticoagulation in Patients With Atrial Fibrillation? Ann Intern Med, September 1, 2009; 151(5): 355 - 356. [Full Text] [PDF]

				R. A. Krasuski, S. A. Hart, D. Allen, A. Qureshi, G. Pettersson, P. L. Houghtaling, L. H. Batizy, and E. Blackstone Prevalence and Repair of Intraoperatively Diagnosed Patent Foramen Ovale and Association With Perioperative Outcomes and Long-term Survival JAMA, July 15, 2009; 302(3): 290 - 297. [Abstract] [Full Text] [PDF]

				R. G. Hart and L. A. Pearce Current Status of Stroke Risk Stratification in Patients With Atrial Fibrillation Stroke, July 1, 2009; 40(7): 2607 - 2610. [Full Text] [PDF]

				R. Nieuwlaat and S. J Connolly Stroke prevention in atrial fibrillation: better use of anticoagulation and new agents will lead to improved outcomes Heart, January 15, 2009; 95(2): 95 - 97. [Full Text] [PDF]

				A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]

				A. Bajpai, I. Savelieva, and A. J. Camm Treatment of atrial fibrillation Br. Med. Bull., December 5, 2008; (2008) ldn046v1. [Abstract] [Full Text] [PDF]